From Pathogen to Infectious Disease Diagnosis
Here is our inaugural podcast with our host, Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, who interviews guests on connecting lab professionals to clinicians and the intricacies of assays, the next generation of diagnostics, and the nuances of interpreting test results.
Silos. This is what medical professionals often work in and they are not frequently presented with the opportunity to work across the medical aisle and collaborate with colleagues working in different specialties. Take for example, laboratory professionals and infectious disease clinicians. The former is securing test results and sending them along to clinicians, and then separately, the providers are reviewing results, interpreting them, and deciphering treatment.
What if you could break down these particular silos and make the connection between the lab and clinicians stronger and enable them to collaborate? With this idea in mind, we have launched our podcast, From Pathogen to Infectious Disease Diagnosis, which takes a deeper look at how the 2 silos can collaborate and come together. We will be doing this with the help of our esteemed podcast host, Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, who is a University Distinguished and Regents’ professor and chair for the Medical Laboratory Science (MLS) Program in the College of Health Professions (CHP) at Texas State University.
Today’s guest is Michael Laposata, MD, PhD, who is the professor and chair of the Department of Pathology at the University of Texas Medical Branch-Galveston. Laposata developed the concept of the Diagnostic Management Team (DMT), which brings lab professionals out of the lab and looks to aid clinicians with interpretation of testing results.1 Additionally, his school, the University of Texas Medical Branch-Galveston, was one of the first universities in the United States that developed a Doctorate of Clinical Laboratory Studies (DCLS) program around the DMT concept.
“The Doctorate of Clinical Laboratory Sciences (DCLS) is an advanced professional doctorate designed for practicing clinical laboratory scientists who wish to further their level of clinical expertise and to develop leadership and management skills. The purpose of the program is the development of clinical laboratory sciences graduates who function as practitioners, community leaders, educators, and scholars in the profession of clinical laboratory science and the discipline of clinical laboratory science,” According to UTMB’s website.2
Today’s episode is the first of a 2-part episode on the DMT novel concept and this evolving field. Sit back and enjoy this first episode. And if you have any ideas for future podcasts or feedback, please email John Parkinson at jparkinson@mjhlifesciences.com.
